A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301
Public ClinicalTrials.gov record NCT01017146. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Acne Vulgaris
Study identification
- NCT ID
- NCT01017146
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Stiefel, a GSK Company
- Industry
- Enrollment
- 744 participants
Conditions and interventions
Conditions
Interventions
- Tazarotene foam Drug
- Vehicle Foam Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 45 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2009
- Primary completion
- Oct 31, 2010
- Completion
- Oct 31, 2010
- Last update posted
- Jan 17, 2017
2009 – 2010
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cherry Creek Research, Inc. | Denver | Colorado | 80209 | — |
| Cosmetic Medicine & Treatment Research Insttitute, Inc. | Miami Beach | Florida | 33140 | — |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46260 | — |
| Minnesota Clinical Study Center | Fridley | Minnesota | 55432 | — |
| Academic Dermatology Associates | Albuquerque | New Mexico | 87106 | — |
| DermResearch Center of New York, Inc. | Stony Brook | New York | 11790 | — |
| Dermatology Consulting Services | High Point | North Carolina | 27262 | — |
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 | — |
| The Dermatology Research of Cincinnati | Cincinnati | Ohio | 45220 | — |
| Group Health Associates | Cincinnatti | Ohio | 45220 | — |
| Haber Dermatology & Cosmetic Surgery, Inc. | South Euclid | Ohio | 44118 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| Yardley Dermatology Associates | Yardley | Pennsylvania | 19067 | — |
| The Skin Wellness Center, PC | Knoxville | Tennessee | 37922 | — |
| Dermatology Research Associates, Inc. | Nashville | Tennessee | 37203 | — |
| DermResearch, Inc. | Austin | Texas | 78759 | — |
| J & S Studies, Inc. | College Station | Texas | 77845 | — |
| Dermatology Treatment & Research Center | Dallas | Texas | 75230 | — |
| Aurora Advanced Healthcare, Inc. Clinical Research Center | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01017146, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 17, 2017 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01017146 live on ClinicalTrials.gov.